Neuroprotective actions and possible underlying molecular mechanisms of valproate

Chinese Pharmacological Bulletin

Volumn 23, Issue 3, 2007, Pages 295-298

  Li, Ling Yun ^a   Qin, Zheng Hong ^a   Liang, Zhong Qin ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Bcl 2; HDAC; MEK MAPK; Neuroprotection; Valproate

Indexed keywords

VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG MECHANISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION;

EID: 34249779518     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Manji H K, Bebchuk J M, Moore G J, et al . Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents; therapeutic implications [J]. J Clin Psychiatry, 1999, 60 (suppl 2): 27-39.
2. Jeong M R, Hashimotoa R, Senatorov V V, et al. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition [J]. FEBS Letters, 2003, 542 (1-3): 74-8.
3. Kanai H, Sawa A, Chen R W, et al. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons [J]. Pharmacogenomics J, 2004, 4(5): 33-44.
4. Ren M, Leng Y, Jeong M R, et al. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction [J]. J Neurochem, 2004, 89(6): 1358-67.
5. Hsieh J, Nakashima K, Kuwabara T, et al. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neuralprogenitor cells [J]. PNAS, 2004, 101(47): 16659-64.
6. Billin A N, Thirlwell H, Ayer D E. Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator [J]. Mol Cell Biol, 2000, 20 (18): 6882-90.
7. Yuan P X, Huang L D, Jiang Y M, et al. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth [J]. J Biol Chem, 2001, 276 (34): 31674-83.
8. Asghari V, Wang J F, Reiach J S, et al. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells [J]. Brain Res Mol Brain Res, 1998, 58 (1-2): 95-102.
9. Chen G, Zeng W Z, Yuan P X, et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS [J]. J Neurochem, 1999, 72(2): 879-82.
10. Hao Y, Creson T, Zhang L. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis [J]. J Neuroscience, 2004, 24 (29): 6590-9.
11. Li J L, Tang C E, Chen Z C, et al. Valproic acid activates ERK21 / 2 signal ing pathway in the rat hippocampus and frontal cortex [J]. Prog Biochem Biophys, 2003, 30 (2): 239-44.
12. Guang H M, Du G H. Involvement of cAMP response element Dinding protein in neurodegenerative disorders [J]. Chin Pharmacol Bull, 2006, 22 (3): 262-6.
13. Chen R W, Chuang D M. Long term lithium treatment suppresses p53 and bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity [J]. J Biol Chem, 1999, 274 (10): 6039-42.
14. Hahn C G, Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder [J]. Bipolar Disorders, 1999, 1 (2): 81-6.
15. Watson D G, Lenox R H. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation [J]. J Neurochem, 1996, 67 (2): 767-77.
16. Chen G, Huang L D, Jiang Y M, et al. The mood stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3 [J]. J Neurochem, 1999, 72 (3): 1327-30.
17. Jin N, Attila D, Kovacs A D, et al. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death [J]. Neuropharmacology, 2005, 48 (4): 576-83.
18. O'Donnell T, Rotzinger S, Nakashima T T, et al. Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain [J]. Eur Neuropsychopharmacol, 2003, 13 (3): 199-207.
19. Ju S, Greenberg M L. Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis [J]. Mol Microbiol, 2003, 49 (6): 1595-603.
20. Shaltiel G, Shamir A, Shapiro J, et al. Valproate decreases inositol biosynthesis [J]. Biol Psychiatry, 2004, 56 (11): 868-74.
21. Bown C D, Wang J F, Young L T. Attenuation of N-methyl-D-aspartate- mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers [J]. Neuroscience, 2003, 117 (4): 949-55.
22. Hassel B, Iversen E G, Gjerstad L, et al. Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate [J]. J Neurochem, 2001, 77 (5): 1285-92.
23. Chen B, Wang J F, Young L T. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus [J]. Biol Psychiatry, 2000, 48 (7): 658-64.
24. Onofrj M, Thomas A, Paci C. Reversible parkinsonism induced by prolonged treatment with valproate [J]. J Neurol, 1998, 245 (12): 794-6.
25. Ichiyama T, Okada K, Lipton J M, et al. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB [J]. Brain Res, 1999, 857 (1-2): 246-51.
26. Peng G S, Li G, Tzeng N S, et al. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia [J]. Brain Res Mol Brain Res, 2005, 134 (1): 162-9.